[Our data show that erlotinib is a multikinase inhibitor, which can act independent of EGFR in PDAC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE